Abstract
Diagnosis of dysglycemic states is likely delayed as current diagnostic criteria apply absolute threshold values to a process that is continuous. The importance of this relates to forestalling opportunities for earlier diagnosis when prevention and reversibility are more likely to occur by preventing further β cell dysfunction. Although the optimal method for earlier identification of individuals at risk remains uncertain, the paper suggests novel approaches.
Original language | English |
---|---|
Pages (from-to) | 66-69 |
Number of pages | 4 |
Journal | Endocrine |
Volume | 44 |
Issue number | 1 |
DOIs | |
State | Published - Aug 2013 |
Keywords
- 1,5-Anhydroglucitol
- Adiponectin
- Diabetes mellitus
- Diabetes prevention
- Dysglycemia
- HbA1c
- IL-1 receptor antagonist
- Impaired fasting glucose
- Impaired glucose tolerance
- Interleukin-1β
- Prediabetes